Experimenting With Disaster, Part 3
By Mara Hvistendahl,
The Intercept
| 11. 01. 2022
High Containment: Lab That Created Risky Avian Flu Had “Unacceptable” Biosafety Protocols
Part 1; Part 2
IT STARTED WITH a bold idea. “Someone finally convinced me to do something really, really stupid,” virologist Ron Fouchier told Scientific American in 2011. Fouchier, of Erasmus Medical Center in Rotterdam, and another scientist, Yoshihiro Kawaoka of the University of Wisconsin–Madison, had separately tweaked the H5N1 virus — an influenza that primarily infects birds — in a way that made it spread more easily in ferrets. H5N1 is a prime pandemic candidate, and ferrets are often used as proxies for humans in flu experiments. When word got out that the two scientists were planning to publish papers detailing their experiments, making a blueprint available to the world, the outcry was extreme. The scientists were trying to better understand H5N1 in order to prevent a pandemic, but critics worried that their experiments could instead cause one — or provide would-be bioterrorists with an outbreak manufacturing guide.
The New York Times ran an editorial titled “An Engineered Doomsday.” The backlash was so severe that in 2012, Kawaoka, Fouchier, and other prominent flu scientists voluntarily agreed to pause the transmissibility work...
Related Articles
By Carissa Wong, New Scientist | 07.08.2026
Healthy lambs have been born via an experimental form of in vitro fertilisation (IVF) that coaxes highly immature eggs to become mature ones in the lab. This is the first time the approach has been demonstrated in a large animal...
By Maggie Astor, The New York Times | 06.23.2026
Every year, patients undergo millions of in vitro fertilization procedures worldwide. Only a minority result in a live birth.
In an effort to improve the odds, scientists have developed an array of “add-ons” that could in theory identify the most...
By Carl Zimmer and Catrin Einhorn, The New York Times | 06.25.2026
The Trump administration and a company that is promising to bring long-gone animals back from extinction announced a partnership on Thursday to preserve cells, tissue and DNA from threatened and endangered species.
The company, Colossal Biosciences, said its goal was...
By Julianna LeMieux, Genetic Engineering & Biotechnology News | 04.14.2026
Twenty years ago, Sven Bocklandt, PhD, sought to create a hypoallergenic cat. He had the genetic engineering chops to do it, but the embryology was beyond his capabilities. At a small animal genetic engineering conference, known as TARC (Transgenic Animal...